Skip to main content

Table 1 Association between B4GALT1 expression and patient characteristics

From: B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients

Characteristic Training set (n = 142) Validation set (n = 112)
Patients B4GALT1 expression Patients B4GALT1 expression
NO. % Low High P NO. % Low High P
Age, years      0.614      0.763
 Mean ± SD 62.4 ± 10.8   61.8 ± 10.9 62.7 ± 10.8   61.5 ± 8.7   61.8 ± 9.7 61.3 ± 7.6  
 Range, median 30–82,62   34–82,62 30–82,62   35–81,62   35–81,62 46–75,61  
Gender      0.925      0.581
 Male 118 83.1 45 73   97 86.6 48 49  
 Female 24 16.9 10 14   15 13.4 9 6  
Tumor size, cm      0.053      0.411
 Mean ± SD 3.8 ± 1.9   4.2 ± 2.1 3.6 ± 1.7   3.8 ± 1.8   3.9 ± 2.0 3.7 ± 1.6  
 Range 0.5–10.0   1.0–10.0 0.5–8.0   0.8–9.5   0.8–9.5 1.3–9.0  
pT stage      0.971      0.720
 T2 68 47.9 27 41   49 43.8 27 22  
 T3 48 33.8 18 30   49 43.8 23 26  
 T4 26 18.3 10 16   14 12.4 7 7  
Grade      0.017      0.950
 low 24 16.9 15 9   11 9.8 6 5  
 high 118 83.1 40 78   101 90.2 51 50  
LVI      0.157      0.741
 absent 53 37.3 25 28   78 69.6 41 37  
 present 89 62.7 30 59   34 30.4 16 18  
CCI      0.116      0.263
  ≤ 1 47 33.1 23 24   44 39.3 19 25  
  ≥ 2 95 66.9 32 63   68 60.7 38 30